Literature DB >> 11132148

HLA-B locus-specific downregulation in human melanoma requires enhancer A as well as a sequence element located downstream of the transcription initiation site.

M Griffioen1, I J Ouwerkerk, V Harten, P I Schrier.   

Abstract

Human MHC class I molecules are encoded by three different loci (HLA-A, -B, and -C), which are regulated at the transcriptional level through several conserved cis-acting promoter elements. The presence of locus-specific residues throughout the entire promoter region strongly suggests that the various HLA class I loci are differentially regulated. To identify regulatory sequences involved in locus-specific HLA class I gene transcription, a series of truncated HLA-A2 and HLA-B7 promoter-reporter constructs were transfected into melanoma cell lines expressing high and low levels of endogenous HLA-B, but comparable levels of HLA-A. These experiments showed that differential regulation of HLA-B expression in melanoma cell lines is mediated by a previously unidentified co-operative action of enhancer A, located 175 bp upstream of the transcription initiation site (+1), and a specific region of 20 nucleotides located at +13 to +33 bp downstream of the transcription initiation site. Furthermore, we demonstrated binding of transcription factor Yin Yang 1 to the HLA-A +13/+33 bp region, but not to the equivalent HLA-B region. Based on these results, we present a model suggesting that YY1 displaces either activating or repressing transcription factors, thereby making the HLA-A gene resistant to differential regulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11132148     DOI: 10.1007/s002510000262

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  4 in total

1.  Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.

Authors:  Chien-Chung Chang; Michael Campoli; Nicholas P Restifo; Xinhui Wang; Soldano Ferrone
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

2.  FcepsilonRIalpha gene -18483A>C polymorphism affects transcriptional activity through YY1 binding.

Authors:  Daniel P Potaczek; Keiko Maeda; Qing-Hui Wang; Nobuhiro Nakano; Shunsuke Kanada; Ewa Stepien; Agnieszka Branicka; Tatsuo Fukai; Mutsuko Hara; Tomoko Tokura; Hideoki Ogawa; Anetta Undas; Ko Okumura; Chiharu Nishiyama
Journal:  Immunogenetics       Date:  2009-08-14       Impact factor: 2.846

3.  Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition.

Authors:  A B Del Campo; J Carretero; J A Muñoz; S Zinchenko; F Ruiz-Cabello; G González-Aseguinolaza; F Garrido; N Aptsiauri
Journal:  Cancer Gene Ther       Date:  2014-06-27       Impact factor: 5.987

Review 4.  HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target.

Authors:  Zahra Souri; Annemijn P A Wierenga; Arend Mulder; Aart G Jochemsen; Martine J Jager
Journal:  Cancers (Basel)       Date:  2019-08-07       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.